Last updated 13 months ago

DApagliflozin Cardiovascular Effects on Patients at End-stage REnal Disease

80 patients around the world

Available in Brazil

University of Campinas, Brazil

1Research sites

80Patients around the world

This study is for people with

Renal disease

End-stage renal disease

To 75 Years

All Gender

: Known allergy to any of the investigational drug components
Current use of sodium-glucose co-transporter 2 inhibitors
Pregnant woman
Myocardial infarction or myocardial revascularization in the past 3 months

Centro de Pesquisa Clínica - UNICAMP

Recruiting

R. Tessália Vieira de Camargo, 126 - Cidade Universitária, Campinas - SP, 13083-887

StudyDare-Esrd

SponsorUniversity of Campinas, Brazil

Study typeInterventional

Conditions

End-stage renal disease

Requirements

To 75 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05685394